Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Joint Commission Journal on Quality and Patient Safety|November 15, 2015
Percent Time in Range with Warfarin as a Performance Measure: How Long a Sampling Frame Is Needed?Adam J Rose, Joel I Reisman, Zayd Razouki, et al.Pain Medicine (Malden, Mass.)|November 8, 2018
Attributes, Attitudes, and Practices of Clinicians Concerned with Opioid PrescribingZayd Razouki, Bushra A Khokhar, Lindsey M Philpot, et al.Journal of Thrombosis and Thrombolysis|April 25, 2018
Anticoagulation reversal in vitamin K antagonist-associated intracerebral hemorrhage: a systematic reviewDarae Ko, Zayd Razouki, James Otis, et al.Circulation. Cardiovascular Quality and Outcomes|September 4, 2014
Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic rangeZayd Razouki, Al Ozonoff, Shibei Zhao, et al.Circulation. Cardiovascular Quality and Outcomes|October 1, 2015
Improving Anticoagulation Measurement Novel Warfarin Composite MeasureZayd Razouki, James F Burgess, Al Ozonoff, et al.BMC Health Services Research|July 6, 2016
Organizational factors associated with Health Care Provider (HCP) influenza campaigns in the Veterans health care system: a qualitative studyZayd Razouki, Troy Knighton, Richard A Martinello, et al.The Journal of Allergy and Clinical Immunology. in Practice|November 6, 2018
A Systematic Review of Patient- and Family-Level Inhaled Corticosteroid Adherence Interventions in Black/African AmericansIsaretta L Riley, Beverly Murphy, Zayd Razouki, et al.Mayo Clinic Proceedings|February 26, 2018
Treatment Effect in Earlier Trials of Patients With Chronic Medical Conditions: A Meta-Epidemiologic StudyFares Alahdab, Wigdan Farah, Jehad Almasri, et al.Urology|May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical TrialsAndrew Fang, Daniel E Frigo, Andrew Hahn, et al.Pageof 1